Back
Novartis AG 10K Form
Buy
93
NVSEF
Novartis AG
Last Price:
100.41
Seasonality Move:
4.4%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVSEF News And Ratings
See the #1 stock for the next 7 days that we like better than NVSEF
NVSEF Financial Statistics
Sales & Book Value
| Annual Sales: | $46.66B |
|---|---|
| Cash Flow: | $1.11B |
| Price / Cash Flow: | 20.66 |
| Annual Sales: | $19.44 |
| Price / Book: | 5.25 |
Profitability
| EPS (TTM): | 7.33000 |
|---|---|
| Net Income (TTM): | $15.25B |
| Gross Margin: | $34.19B |
| Return on Equity: | 33.31% |
| Return on Assets: | 14.38% |
Novartis AG Earnings Forecast
Key Novartis AG Financial Ratios
- The Gross Profit Margin over the past 26 years for NVSEF is 73.27%.
- The Selling, General & Administrative Expenses for NVSEF have been equal to 26.83% of Gross Profit Margin.
- The Research & Development expenses have been 24.37% of Revenue.
- The Interest Expense is 5.76% of Operating Income.
- The Net Earning history of NVSEF is 31.83% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 17 years.
Novartis AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NVSEF |
| Website: | novartis.com |
Debt
| Debt-to-Equity Ratio: | 0.64 |
|---|---|
| Current Ratio: | 0.9 |
| Quick Ratio: | 0.61 |
Price-to-Earnings
| Trailing P/E Ratio: | 14.37 |
|---|---|
| Forward P/E Ratio: | 0 |
NVSEF Technical Analysis vs Fundamental Analysis
Buy
93
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy or a Sell?
-
Novartis AG stock is rated a Buy
The current Novartis AG [NVSEF] share price is $102.00. The Score for NVSEF is 93, which is 86% above its historic median score of 50, and infers lower risk than normal.